Related Experiment Videos
Sonodynamically induced antitumor effect of pheophorbide a
K Umemura1, N Yumita, R Nishigaki
1School of Pharmaceutical Sciences, Toho University, Chiba, Japan.
Cancer Letters
|April 19, 1996
Summary
Pheophorbide a (Ph-a) combined with ultrasound shows a potent sonodynamic antitumor effect. This combination significantly inhibited tumor growth in mice, offering a promising cancer therapy approach.
Area of Science:
- Photodynamic Therapy
- Sonodynamic Therapy
- Cancer Research
Background:
- Pheophorbide a (Ph-a) is a photosensitizer with potential therapeutic applications.
- Ultrasound therapy is an emerging modality for cancer treatment.
- Combining Ph-a with ultrasound may enhance antitumor effects.
Purpose of the Study:
- To investigate the sonodynamic antitumor effect of pheophorbide a (Ph-a).
- To evaluate the combined efficacy of Ph-a and ultrasound on sarcoma 180 in vitro and in vivo.
Main Methods:
- In vitro studies using sarcoma 180 cells in suspension with ultrasound (2 MHz) and Ph-a.
- In vivo studies using sarcoma 180 tumor-bearing mice treated with Ph-a and ultrasound.
- Assessment of cell damage and tumor growth inhibition.
Main Results:
- Ph-a (80 microM) significantly enhanced ultrasonically induced cell damage in vitro.
- Histidine inhibited the Ph-a-enhanced cell damage, suggesting a role for ultrasonically induced oxidation.
- In vivo, 5 mg/kg Ph-a combined with ultrasound halted tumor growth, an effect more pronounced than ultrasound alone.
Conclusions:
- Pheophorbide a exhibits a significant sonodynamic antitumor effect when combined with ultrasound.
- The mechanism may involve ultrasonically induced oxidation.
- This combination therapy presents a promising strategy for sarcoma 180 treatment.